<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="sitemap.xsl"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/sec-casts-its-unwelcome-eye-on-valley-economy</loc><lastmod>2026-06-05T22:16:36-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/sec-casts-its-unwelcome-eye-on-valley-economy" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/sec-casts-its-unwelcome-eye-on-valley-economy" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-gives-back-to-local-and-global-charities</loc><lastmod>2026-05-23T05:30:48-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-gives-back-to-local-and-global-charities" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-gives-back-to-local-and-global-charities" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/silicon-valley-unites-behind-apple</loc><lastmod>2026-06-06T09:20:00-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/silicon-valley-unites-behind-apple" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/silicon-valley-unites-behind-apple" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/talking-venture-capital-and-gaming-at-casual-connect-europe</loc><lastmod>2025-08-26T13:33:44-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/talking-venture-capital-and-gaming-at-casual-connect-europe" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/talking-venture-capital-and-gaming-at-casual-connect-europe" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/novel-suit-over-tattoos-in-video-games-likely-to-fade</loc><lastmod>2026-04-11T04:18:29-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/novel-suit-over-tattoos-in-video-games-likely-to-fade" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/novel-suit-over-tattoos-in-video-games-likely-to-fade" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/lawyers-take-pulse-at-healthcare-conference</loc><lastmod>2026-05-16T17:48:38-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/lawyers-take-pulse-at-healthcare-conference" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/lawyers-take-pulse-at-healthcare-conference" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/imf-unable-to-supply-the-currency-needed-to-counter-speculative-attack-using-bitcoin</loc><lastmod>2026-04-30T14:04:01-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/imf-unable-to-supply-the-currency-needed-to-counter-speculative-attack-using-bitcoin" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/imf-unable-to-supply-the-currency-needed-to-counter-speculative-attack-using-bitcoin" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-helps-crush-5-9-billion-deal</loc><lastmod>2026-01-28T13:20:24-05:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-helps-crush-5-9-billion-deal" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-helps-crush-5-9-billion-deal" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-among-top-firms-handling-ip-litigation-for-the-fortune-500</loc><lastmod>2025-08-25T15:37:50-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-among-top-firms-handling-ip-litigation-for-the-fortune-500" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-among-top-firms-handling-ip-litigation-for-the-fortune-500" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/health-care-ipos-strong-in-market-downturn</loc><lastmod>2026-06-08T07:37:19-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/health-care-ipos-strong-in-market-downturn" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/health-care-ipos-strong-in-market-downturn" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-helps-clash-of-clans-developer-score-early-win-under-alice</loc><lastmod>2026-06-11T02:31:30-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-helps-clash-of-clans-developer-score-early-win-under-alice" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-helps-clash-of-clans-developer-score-early-win-under-alice" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-nabs-ex-dechert-life-sciences-pro-for-ip-practice</loc><lastmod>2025-08-27T02:57:50-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-nabs-ex-dechert-life-sciences-pro-for-ip-practice" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-nabs-ex-dechert-life-sciences-pro-for-ip-practice" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-secures-win-for-lelo-inc-in-precedential-federal-circuit-patent-ruling-limiting-the-itcs-jurisdiction</loc><lastmod>2025-08-27T23:43:30-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-secures-win-for-lelo-inc-in-precedential-federal-circuit-patent-ruling-limiting-the-itcs-jurisdiction" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-secures-win-for-lelo-inc-in-precedential-federal-circuit-patent-ruling-limiting-the-itcs-jurisdiction" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/co-founder-feuds-at-l-a-tech-start-ups-show-how-handshake-deals-can-blow-up</loc><lastmod>2025-08-27T10:54:50-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/co-founder-feuds-at-l-a-tech-start-ups-show-how-handshake-deals-can-blow-up" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/co-founder-feuds-at-l-a-tech-start-ups-show-how-handshake-deals-can-blow-up" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-ipo-report-reveals-divergence-in-life-sciences-tech-ipo-structures</loc><lastmod>2025-08-23T23:51:35-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-ipo-report-reveals-divergence-in-life-sciences-tech-ipo-structures" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-ipo-report-reveals-divergence-in-life-sciences-tech-ipo-structures" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-works-on-californias-largest-ipos-acquisitions-of-the-year</loc><lastmod>2025-08-23T19:02:40-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-works-on-californias-largest-ipos-acquisitions-of-the-year" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-works-on-californias-largest-ipos-acquisitions-of-the-year" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/ipos-lag-follow-on-offerings-strong-in-february</loc><lastmod>2025-08-27T14:39:43-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ipos-lag-follow-on-offerings-strong-in-february" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ipos-lag-follow-on-offerings-strong-in-february" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-public-offerings-alive-in-2015</loc><lastmod>2026-06-05T05:39:03-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-public-offerings-alive-in-2015" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-public-offerings-alive-in-2015" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/pros-and-cons-of-splits-and-divestitures</loc><lastmod>2026-06-09T22:31:51-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/pros-and-cons-of-splits-and-divestitures" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/pros-and-cons-of-splits-and-divestitures" /><image:image><image:loc>https://assets.fenwick.com/banner-images/NEWS_Banner-Image@2x.webp</image:loc><image:title>NEWS Banner Image 2x</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/middle-market-ipos-soar-despite-drop-in-capital-raised</loc><lastmod>2025-08-28T06:45:42-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/middle-market-ipos-soar-despite-drop-in-capital-raised" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/middle-market-ipos-soar-despite-drop-in-capital-raised" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/companies-and-lawyers-may-face-securities-law-problems-in-hacking-scheme</loc><lastmod>2024-09-25T07:19:15-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/companies-and-lawyers-may-face-securities-law-problems-in-hacking-scheme" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/companies-and-lawyers-may-face-securities-law-problems-in-hacking-scheme" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/patton-video-game-sparks-war-over-generals-likeness</loc><lastmod>2025-08-28T04:51:10-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/patton-video-game-sparks-war-over-generals-likeness" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/patton-video-game-sparks-war-over-generals-likeness" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/senator-cites-article-by-charlene-morrow-brian-lahti-in-congressional-address</loc><lastmod>2026-06-10T07:21:34-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/senator-cites-article-by-charlene-morrow-brian-lahti-in-congressional-address" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/senator-cites-article-by-charlene-morrow-brian-lahti-in-congressional-address" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/ip-trailblazer-fenwick-wests-sally-abel</loc><lastmod>2025-08-28T07:25:38-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ip-trailblazer-fenwick-wests-sally-abel" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ip-trailblazer-fenwick-wests-sally-abel" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/high-court-appears-split-on-claim-construction-deference</loc><lastmod>2025-08-25T07:02:11-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/high-court-appears-split-on-claim-construction-deference" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/high-court-appears-split-on-claim-construction-deference" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-hires-17-year-sec-enforcement-vet-in-sf</loc><lastmod>2025-08-27T16:27:35-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-hires-17-year-sec-enforcement-vet-in-sf" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-hires-17-year-sec-enforcement-vet-in-sf" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-nabs-sec-associate-regional-director-in-sf</loc><lastmod>2025-08-27T06:23:11-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-nabs-sec-associate-regional-director-in-sf" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-nabs-sec-associate-regional-director-in-sf" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-snares-sec-enforcement-lawyer</loc><lastmod>2025-08-26T13:25:44-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-snares-sec-enforcement-lawyer" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-snares-sec-enforcement-lawyer" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/former-fenwick-partner-michelle-lee-rumored-choice-for-uspto-director</loc><lastmod>2025-08-25T20:18:54-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/former-fenwick-partner-michelle-lee-rumored-choice-for-uspto-director" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/former-fenwick-partner-michelle-lee-rumored-choice-for-uspto-director" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/oxycontin-cialis-makers-avoid-court-in-bid-to-win-patent-fights</loc><lastmod>2026-06-05T00:39:50-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/oxycontin-cialis-makers-avoid-court-in-bid-to-win-patent-fights" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/oxycontin-cialis-makers-avoid-court-in-bid-to-win-patent-fights" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/coping-with-the-challenges-of-small-companies</loc><lastmod>2025-08-27T15:14:26-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/coping-with-the-challenges-of-small-companies" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/coping-with-the-challenges-of-small-companies" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/women-leaders-in-tech-law-sally-abel</loc><lastmod>2025-08-27T22:51:46-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/women-leaders-in-tech-law-sally-abel" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/women-leaders-in-tech-law-sally-abel" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-companies-create-demand-for-sexy-legal-work</loc><lastmod>2026-05-15T13:59:12-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-companies-create-demand-for-sexy-legal-work" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-companies-create-demand-for-sexy-legal-work" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/report-life-sciences-ipos-the-big-kahuna</loc><lastmod>2025-08-24T04:09:08-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/report-life-sciences-ipos-the-big-kahuna" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/report-life-sciences-ipos-the-big-kahuna" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/report-fenwick-study-points-to-rising-valuations-but-dont-call-it-a-bubble</loc><lastmod>2025-08-23T17:11:49-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/report-fenwick-study-points-to-rising-valuations-but-dont-call-it-a-bubble" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/report-fenwick-study-points-to-rising-valuations-but-dont-call-it-a-bubble" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/community-change-and-innovation-law-firms-make-virtual-help-a-reality</loc><lastmod>2026-05-23T07:45:07-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/community-change-and-innovation-law-firms-make-virtual-help-a-reality" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/community-change-and-innovation-law-firms-make-virtual-help-a-reality" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/cellectar-an-otc-stock-eyes-nasdaq-jump-to-boost-profile-prospects</loc><lastmod>2026-06-06T18:15:50-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/cellectar-an-otc-stock-eyes-nasdaq-jump-to-boost-profile-prospects" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/cellectar-an-otc-stock-eyes-nasdaq-jump-to-boost-profile-prospects" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/young-companies-embrace-the-jobs-act</loc><lastmod>2026-06-04T20:03:57-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/young-companies-embrace-the-jobs-act" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/young-companies-embrace-the-jobs-act" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/first-quarter-increase-in-start-up-valuations</loc><lastmod>2026-04-29T22:35:18-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/first-quarter-increase-in-start-up-valuations" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/first-quarter-increase-in-start-up-valuations" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/heres-the-totally-amazing-wonder-material-that-could-revolutionize-technology</loc><lastmod>2025-08-28T02:05:58-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/heres-the-totally-amazing-wonder-material-that-could-revolutionize-technology" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/heres-the-totally-amazing-wonder-material-that-could-revolutionize-technology" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/digital-health-check-up-more-dollars-fewer-bracelets</loc><lastmod>2026-05-15T20:30:36-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/digital-health-check-up-more-dollars-fewer-bracelets" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/digital-health-check-up-more-dollars-fewer-bracelets" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/the-opening-of-fenwick-wests-office-in-shanghai-china-was-featured-in-bloomberg-law</loc><lastmod>2025-08-28T09:36:38-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/the-opening-of-fenwick-wests-office-in-shanghai-china-was-featured-in-bloomberg-law" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/the-opening-of-fenwick-wests-office-in-shanghai-china-was-featured-in-bloomberg-law" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-opens-first-international-office-in-china</loc><lastmod>2025-08-26T12:20:30-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-opens-first-international-office-in-china" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-opens-first-international-office-in-china" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-to-open-shanghai-office</loc><lastmod>2025-08-27T19:58:29-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-to-open-shanghai-office" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-to-open-shanghai-office" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/rising-star-fenwick-wests-tyler-newby</loc><lastmod>2025-08-25T01:18:34-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/rising-star-fenwick-wests-tyler-newby" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/rising-star-fenwick-wests-tyler-newby" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/when-the-ceo-cant-stop-tweeting</loc><lastmod>2026-06-06T09:51:25-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/when-the-ceo-cant-stop-tweeting" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/when-the-ceo-cant-stop-tweeting" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/wearable-technology-raises-pivotal-legal-questions</loc><lastmod>2024-09-25T17:39:37-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/wearable-technology-raises-pivotal-legal-questions" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/wearable-technology-raises-pivotal-legal-questions" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/already-on-an-ipo-high-biotech-looks-for-a-sequel-to-the-jobs-act</loc><lastmod>2026-06-07T13:48:53-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/already-on-an-ipo-high-biotech-looks-for-a-sequel-to-the-jobs-act" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/already-on-an-ipo-high-biotech-looks-for-a-sequel-to-the-jobs-act" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/at-two-year-mark-jobs-act-is-regulation-even-a-biotech-can-love</loc><lastmod>2026-06-05T17:40:07-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/at-two-year-mark-jobs-act-is-regulation-even-a-biotech-can-love" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/at-two-year-mark-jobs-act-is-regulation-even-a-biotech-can-love" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/rising-star-fenwick-wests-michael-brown</loc><lastmod>2025-08-28T10:57:16-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/rising-star-fenwick-wests-michael-brown" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/rising-star-fenwick-wests-michael-brown" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/confidential-ipo-filings-favored-by-tech-and-life-sciences-companies</loc><lastmod>2025-08-28T11:06:34-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/confidential-ipo-filings-favored-by-tech-and-life-sciences-companies" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/confidential-ipo-filings-favored-by-tech-and-life-sciences-companies" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-tech-ipos-soared-in-2013</loc><lastmod>2025-08-27T01:44:27-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-tech-ipos-soared-in-2013" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-tech-ipos-soared-in-2013" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/early-signs-of-tech-turbulence-may-have-surfaced-late-last-year</loc><lastmod>2025-08-21T15:42:46-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/early-signs-of-tech-turbulence-may-have-surfaced-late-last-year" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/early-signs-of-tech-turbulence-may-have-surfaced-late-last-year" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-tech-ipos-rise-fenwick-says</loc><lastmod>2025-08-22T20:08:12-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-tech-ipos-rise-fenwick-says" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-tech-ipos-rise-fenwick-says" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/partner-michael-esquivel-profiled-by-the-recorder</loc><lastmod>2026-05-15T11:32:10-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/partner-michael-esquivel-profiled-by-the-recorder" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/partner-michael-esquivel-profiled-by-the-recorder" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/outlook-for-ipos-in-2014</loc><lastmod>2026-06-05T10:24:37-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/outlook-for-ipos-in-2014" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/outlook-for-ipos-in-2014" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/the-one-mistake-startup-entrepreneurs-always-make-a-legal-perspective</loc><lastmod>2025-08-21T12:04:38-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/the-one-mistake-startup-entrepreneurs-always-make-a-legal-perspective" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/the-one-mistake-startup-entrepreneurs-always-make-a-legal-perspective" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/corporate-attorneys-unfazed-by-spate-of-biotech-ipo-postponements</loc><lastmod>2026-05-15T22:12:06-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/corporate-attorneys-unfazed-by-spate-of-biotech-ipo-postponements" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/corporate-attorneys-unfazed-by-spate-of-biotech-ipo-postponements" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/why-ipos-are-up-and-m-a-is-down</loc><lastmod>2025-08-27T05:17:35-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/why-ipos-are-up-and-m-a-is-down" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/why-ipos-are-up-and-m-a-is-down" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/californias-bustling-biotechnology-industry</loc><lastmod>2026-06-10T23:55:01-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/californias-bustling-biotechnology-industry" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/californias-bustling-biotechnology-industry" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/twitter-ipo-unlikely-to-be-hurt-by-federal-shutdown-unless-it-drags-on</loc><lastmod>2026-06-05T15:12:33-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/twitter-ipo-unlikely-to-be-hurt-by-federal-shutdown-unless-it-drags-on" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/twitter-ipo-unlikely-to-be-hurt-by-federal-shutdown-unless-it-drags-on" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/alibaba-questions-hong-kong-exchanges-stance</loc><lastmod>2026-06-10T21:37:03-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/alibaba-questions-hong-kong-exchanges-stance" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/alibaba-questions-hong-kong-exchanges-stance" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/why-confidential-filings-are-the-new-normal-for-ipos</loc><lastmod>2026-06-05T22:18:14-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/why-confidential-filings-are-the-new-normal-for-ipos" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/why-confidential-filings-are-the-new-normal-for-ipos" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/israel-a-hub-for-cross-border-m-a-work</loc><lastmod>2025-08-28T03:26:14-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/israel-a-hub-for-cross-border-m-a-work" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/israel-a-hub-for-cross-border-m-a-work" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/scotus-refuses-to-sink-pay-for-delay-settlements</loc><lastmod>2025-08-26T12:43:40-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/scotus-refuses-to-sink-pay-for-delay-settlements" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/scotus-refuses-to-sink-pay-for-delay-settlements" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/licensing-and-ip-issues-for-mobile-and-social-game-developers</loc><lastmod>2026-05-22T19:01:55-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/licensing-and-ip-issues-for-mobile-and-social-game-developers" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/licensing-and-ip-issues-for-mobile-and-social-game-developers" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/law-students-adhd-illegally-revealed-9th-circuit-hears</loc><lastmod>2025-08-23T15:39:11-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/law-students-adhd-illegally-revealed-9th-circuit-hears" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/law-students-adhd-illegally-revealed-9th-circuit-hears" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-sets-course-for-china</loc><lastmod>2025-08-27T03:45:20-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-sets-course-for-china" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-sets-course-for-china" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/lawyers-share-thoughts-on-sec-social-media-guidance</loc><lastmod>2025-08-27T00:28:27-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/lawyers-share-thoughts-on-sec-social-media-guidance" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/lawyers-share-thoughts-on-sec-social-media-guidance" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/its-hard-work-taking-tech-companies-public</loc><lastmod>2025-08-25T00:50:09-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/its-hard-work-taking-tech-companies-public" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/its-hard-work-taking-tech-companies-public" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-client-moderna-therapeutics-signs-groundbreaking-240m-license-agreement-with-astrazeneca</loc><lastmod>2026-06-05T08:51:04-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-client-moderna-therapeutics-signs-groundbreaking-240m-license-agreement-with-astrazeneca" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-client-moderna-therapeutics-signs-groundbreaking-240m-license-agreement-with-astrazeneca" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/settling-is-not-the-only-way-to-resolve-an-employee-lawsuit</loc><lastmod>2025-08-27T10:24:11-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/settling-is-not-the-only-way-to-resolve-an-employee-lawsuit" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/settling-is-not-the-only-way-to-resolve-an-employee-lawsuit" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/has-mobile-health-monitoring-hit-a-wall</loc><lastmod>2026-05-16T10:54:22-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/has-mobile-health-monitoring-hit-a-wall" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/has-mobile-health-monitoring-hit-a-wall" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/top-deals-2012-m-as-and-ipos</loc><lastmod>2025-08-28T01:56:26-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/top-deals-2012-m-as-and-ipos" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/top-deals-2012-m-as-and-ipos" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-cases-to-watch-in-2013</loc><lastmod>2026-06-04T17:59:34-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-cases-to-watch-in-2013" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/life-sciences-cases-to-watch-in-2013" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/big-med-tech-companies-snap-up-personalized-medicine-start-ups</loc><lastmod>2026-05-15T11:40:39-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/big-med-tech-companies-snap-up-personalized-medicine-start-ups" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/big-med-tech-companies-snap-up-personalized-medicine-start-ups" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/dow-chemical-loses-u-s-court-test-of-r-d-tax-credits</loc><lastmod>2026-06-11T12:38:58-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/dow-chemical-loses-u-s-court-test-of-r-d-tax-credits" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/dow-chemical-loses-u-s-court-test-of-r-d-tax-credits" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/meet-the-superlawyer-who-just-clinched-facebooks-deal-to-buy-instagram</loc><lastmod>2026-06-10T07:20:25-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/meet-the-superlawyer-who-just-clinched-facebooks-deal-to-buy-instagram" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/meet-the-superlawyer-who-just-clinched-facebooks-deal-to-buy-instagram" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-vc-survey-q2-funding-valuations-shoot-the-moon</loc><lastmod>2025-08-26T03:54:24-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-vc-survey-q2-funding-valuations-shoot-the-moon" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-vc-survey-q2-funding-valuations-shoot-the-moon" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/circuit-court-rehears-myriad-case-in-wake-of-prometheus-ruling</loc><lastmod>2026-06-07T03:10:58-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/circuit-court-rehears-myriad-case-in-wake-of-prometheus-ruling" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/circuit-court-rehears-myriad-case-in-wake-of-prometheus-ruling" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/myriad-genetics-patent-case-could-get-messy-with-the-laws-of-nature-and-analogies</loc><lastmod>2026-06-05T06:54:19-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/myriad-genetics-patent-case-could-get-messy-with-the-laws-of-nature-and-analogies" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/myriad-genetics-patent-case-could-get-messy-with-the-laws-of-nature-and-analogies" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/clients-in-the-news-suprema-comes-back-in-a-big-way</loc><lastmod>2025-08-25T05:35:47-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/clients-in-the-news-suprema-comes-back-in-a-big-way" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/clients-in-the-news-suprema-comes-back-in-a-big-way" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/the-boom-in-secret-ipos</loc><lastmod>2026-06-06T10:45:06-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/the-boom-in-secret-ipos" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/the-boom-in-secret-ipos" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/generics-high-court-win-opens-new-battleground-with-pharmas</loc><lastmod>2026-06-06T11:19:54-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/generics-high-court-win-opens-new-battleground-with-pharmas" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/generics-high-court-win-opens-new-battleground-with-pharmas" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/california-arbitration-ruling-seeks-to-dodge-concepcion</loc><lastmod>2026-06-06T22:45:36-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/california-arbitration-ruling-seeks-to-dodge-concepcion" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/california-arbitration-ruling-seeks-to-dodge-concepcion" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/much-ado-about-discovery</loc><lastmod>2026-06-05T18:40:17-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/much-ado-about-discovery" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/much-ado-about-discovery" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/doctors-fear-copyright-crackdown-on-medical-procedures</loc><lastmod>2025-08-21T19:43:30-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/doctors-fear-copyright-crackdown-on-medical-procedures" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/doctors-fear-copyright-crackdown-on-medical-procedures" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/sec-clamps-down-on-secrecy-in-foreign-ipos</loc><lastmod>2026-06-05T11:11:34-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/sec-clamps-down-on-secrecy-in-foreign-ipos" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/sec-clamps-down-on-secrecy-in-foreign-ipos" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/prometheus-unbound-or-not</loc><lastmod>2026-06-06T03:34:56-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/prometheus-unbound-or-not" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/prometheus-unbound-or-not" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/why-the-tech-pre-ipo-market-is-still-rocking</loc><lastmod>2026-03-25T22:46:37-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/why-the-tech-pre-ipo-market-is-still-rocking" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/why-the-tech-pre-ipo-market-is-still-rocking" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/two-fenwick-west-partners-named-as-top-biotech-lawyers-for-2011</loc><lastmod>2026-06-06T12:19:06-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/two-fenwick-west-partners-named-as-top-biotech-lawyers-for-2011" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/two-fenwick-west-partners-named-as-top-biotech-lawyers-for-2011" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/ipos-falling-victim-to-market-decline</loc><lastmod>2026-06-08T05:05:03-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ipos-falling-victim-to-market-decline" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ipos-falling-victim-to-market-decline" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/a-wake-up-call-for-21st-century-employers</loc><lastmod>2026-04-29T11:27:40-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/a-wake-up-call-for-21st-century-employers" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/a-wake-up-call-for-21st-century-employers" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/what-to-do-when-an-employee-departs-suddenly</loc><lastmod>2025-08-27T16:37:44-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/what-to-do-when-an-employee-departs-suddenly" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/what-to-do-when-an-employee-departs-suddenly" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/sec-makes-it-easier-for-investors-to-nominate-corporate-directors</loc><lastmod>2026-06-05T10:26:45-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/sec-makes-it-easier-for-investors-to-nominate-corporate-directors" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/sec-makes-it-easier-for-investors-to-nominate-corporate-directors" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/lateral-data-viewpoint-works-for-fenwick-west</loc><lastmod>2026-06-13T05:29:59-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/lateral-data-viewpoint-works-for-fenwick-west" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/lateral-data-viewpoint-works-for-fenwick-west" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/patenting-nature-and-seattle-biotech</loc><lastmod>2026-06-09T22:20:14-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/patenting-nature-and-seattle-biotech" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/patenting-nature-and-seattle-biotech" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/data-domain-a-hall-of-famer-for-its-advisers</loc><lastmod>2026-06-11T00:32:41-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/data-domain-a-hall-of-famer-for-its-advisers" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/data-domain-a-hall-of-famer-for-its-advisers" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/doctoring-the-lilly-doctrine</loc><lastmod>2026-06-07T13:35:54-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/doctoring-the-lilly-doctrine" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/doctoring-the-lilly-doctrine" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/technology-transfer-considerations-for-stem-cell-technologies</loc><lastmod>2026-06-05T11:11:52-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/technology-transfer-considerations-for-stem-cell-technologies" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/technology-transfer-considerations-for-stem-cell-technologies" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/madoff-behind-bars-but-probe-grinds-forward</loc><lastmod>2026-06-04T22:53:42-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/madoff-behind-bars-but-probe-grinds-forward" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/madoff-behind-bars-but-probe-grinds-forward" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/patents-for-human-genes-face-legal-challenge</loc><lastmod>2026-06-05T11:13:47-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/patents-for-human-genes-face-legal-challenge" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/patents-for-human-genes-face-legal-challenge" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/gileads-hypertension-drug-darusentan-will-likely-receive-patent-extension-attorneys-say</loc><lastmod>2026-06-05T09:59:59-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/gileads-hypertension-drug-darusentan-will-likely-receive-patent-extension-attorneys-say" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/gileads-hypertension-drug-darusentan-will-likely-receive-patent-extension-attorneys-say" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/m-a-activity-likely-to-heat-up-in-stem-cell-space-following-reversal-on-federal-funding-experts-say</loc><lastmod>2025-08-26T04:31:00-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/m-a-activity-likely-to-heat-up-in-stem-cell-space-following-reversal-on-federal-funding-experts-say" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/m-a-activity-likely-to-heat-up-in-stem-cell-space-following-reversal-on-federal-funding-experts-say" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/green-ip-a-thorny-challenge</loc><lastmod>2025-08-23T10:45:43-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/green-ip-a-thorny-challenge" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/green-ip-a-thorny-challenge" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/mid-year-report-on-insider-trading-enforcement</loc><lastmod>2026-06-06T04:15:44-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/mid-year-report-on-insider-trading-enforcement" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/mid-year-report-on-insider-trading-enforcement" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-donates-attorneys-fees-to-public-interest-law-firm</loc><lastmod>2026-06-11T07:29:50-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-donates-attorneys-fees-to-public-interest-law-firm" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-donates-attorneys-fees-to-public-interest-law-firm" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/it-pros-climb-out-of-the-basement</loc><lastmod>2026-06-12T15:35:19-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/it-pros-climb-out-of-the-basement" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/it-pros-climb-out-of-the-basement" /><image:image><image:loc>https://assets.fenwick.com/banner-images/MEDIA_COVERAGE_2Banner-Image.jpg</image:loc><image:title>MEDIA COVERAGE 2 Banner Image</image:title></image:image></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/how-to-make-associates-stick-around</loc><lastmod>2025-11-19T11:42:35-05:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/how-to-make-associates-stick-around" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/how-to-make-associates-stick-around" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/schwarz-jumps-into-pharma-consolidation-trend</loc><lastmod>2026-06-06T04:05:44-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/schwarz-jumps-into-pharma-consolidation-trend" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/schwarz-jumps-into-pharma-consolidation-trend" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/digging-through-the-game-glut</loc><lastmod>2025-08-27T02:02:18-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/digging-through-the-game-glut" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/digging-through-the-game-glut" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/ariad-v-lilly-part-ii-the-next-big-patent-battle</loc><lastmod>2026-06-05T12:28:11-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ariad-v-lilly-part-ii-the-next-big-patent-battle" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/ariad-v-lilly-part-ii-the-next-big-patent-battle" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/pharmaceutical-giants-view-biotech-players-as-key-to-the-future</loc><lastmod>2026-06-10T12:29:04-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/pharmaceutical-giants-view-biotech-players-as-key-to-the-future" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/pharmaceutical-giants-view-biotech-players-as-key-to-the-future" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/stem-cells-from-dc-to-ca</loc><lastmod>2026-06-12T15:37:23-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/stem-cells-from-dc-to-ca" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/stem-cells-from-dc-to-ca" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/bush-maintains-hard-stance-on-stem-cell-bill</loc><lastmod>2026-06-11T08:06:26-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/bush-maintains-hard-stance-on-stem-cell-bill" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/bush-maintains-hard-stance-on-stem-cell-bill" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/securities-partner-horace-nash-selected-as-2005-dealmaker-of-the-year-by-american-lawyer-magazine</loc><lastmod>2026-06-05T11:14:24-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/securities-partner-horace-nash-selected-as-2005-dealmaker-of-the-year-by-american-lawyer-magazine" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/securities-partner-horace-nash-selected-as-2005-dealmaker-of-the-year-by-american-lawyer-magazine" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwicks-tyler-baker-and-mark-ostrau-are-featured-in-the-march-2006-issue-of-global-competition-review</loc><lastmod>2025-08-24T23:27:40-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwicks-tyler-baker-and-mark-ostrau-are-featured-in-the-march-2006-issue-of-global-competition-review" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwicks-tyler-baker-and-mark-ostrau-are-featured-in-the-march-2006-issue-of-global-competition-review" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-wins-2005-award-for-most-innovative-use-of-technology-by-a-law-firm</loc><lastmod>2026-06-10T16:37:28-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-wins-2005-award-for-most-innovative-use-of-technology-by-a-law-firm" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-wins-2005-award-for-most-innovative-use-of-technology-by-a-law-firm" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/400m-compuware-settlement-against-ibm-one-of-the-largest-ip-litigation-payouts-of-2005</loc><lastmod>2025-08-27T09:49:29-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/400m-compuware-settlement-against-ibm-one-of-the-largest-ip-litigation-payouts-of-2005" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/400m-compuware-settlement-against-ibm-one-of-the-largest-ip-litigation-payouts-of-2005" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/24-fenwick-west-partners-honored-as-super-lawyers-of-northern-california</loc><lastmod>2025-08-28T11:13:06-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/24-fenwick-west-partners-honored-as-super-lawyers-of-northern-california" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/24-fenwick-west-partners-honored-as-super-lawyers-of-northern-california" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-joins-in-stem-cell-initiatives</loc><lastmod>2026-06-12T10:02:39-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-joins-in-stem-cell-initiatives" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/fenwick-west-joins-in-stem-cell-initiatives" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/dr-michael-shusters-radio-interview-on-world-talk-radios-biotech-today</loc><lastmod>2025-08-27T17:23:34-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/dr-michael-shusters-radio-interview-on-world-talk-radios-biotech-today" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/dr-michael-shusters-radio-interview-on-world-talk-radios-biotech-today" /></url><url><loc>https://production.fenwick.leeroy.codes/insights/media-coverage/bay-areas-ipo-dry-spell-ends-with-offering-by-formfactor</loc><lastmod>2026-06-12T15:23:54-04:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority><xhtml:link rel="alternate" hreflang="x-default" href="https://production.fenwick.leeroy.codes/insights/media-coverage/bay-areas-ipo-dry-spell-ends-with-offering-by-formfactor" /><xhtml:link rel="alternate" hreflang="en-us" href="https://production.fenwick.leeroy.codes/insights/media-coverage/bay-areas-ipo-dry-spell-ends-with-offering-by-formfactor" /></url></urlset>